Is prism the same kind of compensation as glasses?

Not exactly. Prism doesn't fully neutralize a deviation the way a spectacle lens neutralizes a refractive error — it shifts image location and reduces demand rather than eliminating it. Dosage matters too: prism above roughly 3 prism diopters tends to function compensatorily, while 3PD and under often sits in therapeutic territory, and under 2PD moves into micro-prism dosing specifically.

Is patching for amblyopia a form of compensation?

Not in the strict sense. Patching isn't optically offsetting anything — it forces monocular use rather than neutralizing a demand. It produces a real but different kind of change: improved monocular acuity through homeostatic plasticity, a genuine but temporary neural adaptation that tends to reverse once the patch is removed, without addressing the suppression underneath it.

Do you have to choose between compensation and rehabilitation?

No, and framing it as an either/or choice misses how treatment planning actually works. Unlike medicine's typically one-to-one relationship — an antibiotic for an infection — visual treatment usually combines tools: a therapeutic-dose prism alongside active vision therapy, or a modest lens reducing demand while oculomotor training builds capacity. Most real treatment plans use several tools together rather than picking one approach exclusively.

Compensation vs. Rehabilitation: What Are We Actually Training?

Q: What does compensation actually mean in eye care?

True compensation offsets a problem optically so the demand on the visual system disappears, without changing the underlying condition at all — minus-powered spectacles for myopia or plus for hyperopia are the clearest example. The refractive state is unchanged; it's simply neutralized by the correction.

The pillar's compensation-versus-rehabilitation table is a useful starting frame, but the reality underneath it is more nuanced than a clean two-column split once you look closely at specific tools — particularly prism and patching, which don't sit neatly in either box.

What Compensation Actually Means

True compensation offsets a problem optically so that the demand on the visual system effectively disappears, without changing the underlying condition at all. Minus-powered spectacles for myopia, or plus power for hyperopia, are the clearest examples — the refractive state hasn't changed one bit, it's simply neutralized by the correction sitting in front of the eye. The problem still exists, entirely unchanged, underneath the compensation. That's the defining feature: nothing about the eye itself is different, only what's covering for it.

Prism Doesn't Fit the Same Model

Prism is a different category, and dosage is what actually determines where a given prescription sits. Prism doesn't fully neutralize a phoria or tropia the way a spectacle lens neutralizes a refractive error — it shifts image location and reduces the vergence work required rather than eliminating that work outright. Compensatory prism, in practice, tends to run higher than 3 prism diopters, functioning much like the spectacle example above: reducing demand without training anything. At 3PD and under, prism moves out of purely compensatory territory and into what's often considered a therapeutic dose — prescribed specifically to stimulate and challenge the vergence system rather than simply relieve it of work. Under 2PD specifically enters micro-prism territory, a dosing approach built around subtle recalibration of the system's resting posture rather than either full compensation or an overt training stimulus.

Why Patching Isn't Actually Compensation Either

Patching for amblyopia gets grouped with compensation by default, but it doesn't fit the model at all. It isn't optically offsetting anything — it forces monocular use by removing the fellow eye from the visual task entirely, rather than neutralizing a refractive or vergence demand the way glasses or prism do. What patching produces is real, measurable change: improved monocular acuity in the amblyopic eye. But the underlying problem — suppression, the brain's failure to properly integrate input from both eyes together — persists entirely unchanged underneath that acuity gain.

The mechanism explains why. Patching's gains come from homeostatic plasticity: genuine but temporary neural adaptation that tends to dissipate once the patch comes off, in contrast to the durable Hebbian plasticity that binocular retraining produces. Patching produces real neural change. It's just not the kind of change that resolves the actual underlying binocular dysfunction, and it isn't durable change either.

Why This Isn't Really a "Versus"

Despite the framing this post opened with, compensation and rehabilitation aren't competing choices where picking one rules out the other. Visual treatment planning uses whatever combination of tools a given presentation actually calls for — a therapeutic-dose prism supporting active vision therapy, a modest lens reducing accommodative demand while oculomotor training builds capacity, even patching used briefly and specifically alongside binocular activities rather than as a standalone protocol. Medicine often works in a cleaner one-to-one relationship: an antibiotic treats an infection, and that's largely the whole story. Visual treatment rarely works that way. Using every appropriate tool together, rather than treating this as a binary choice between compensating and rehabilitating, is usually what a real treatment plan actually looks like.

The Actual Point

Compensation and rehabilitation aren't two clean boxes — different tools sit at different points along a spectrum depending on their dose, their mechanism, and how durable the change they produce actually is. Knowing where a specific intervention genuinely sits, rather than assuming based on category alone, is what determines whether a given treatment is actually training something or just managing it.